Attaining glycemic targets for people with type 1 diabetes (T1D) requires lifelong adherence to glucose monitoring and insulin therapy along with real-time adjustments to insulin delivery to account for variations in diet and activity. Here, INS is linked to type 1 diabetes mellitus.